LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

Inicio・Lista de Acciones・Johnson and Johnson

Johnson and Johnson

Cerrado

Sector Salud

164.37 -0.29

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

164.14

Máximo

164.71

Métricas clave
By Trading Economics
Ingresos	1.4B 4.7B
Ventas	1.1B 22B
P/B Media del Sector	21.72 103.001
BPA	2.82
Margen de beneficio	20.873
Empleados	131,900
EBITDA	2.1B 7.8B

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+4.92 upside

Dividendos
By Dow Jones
Próximas Ganancias	15 oct 2024
Fecha Próximo Dividendo	10 sept 2024
Próxima Fecha de Ex Dividendo	18 nov 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	400B
Apertura anterior	164.66
Cierre anterior	164.37

Noticias sobre sentimiento de mercado

By Acuity

55%

45%

293 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

164.13 / 164.61 Soporte y Resistencia

Johnson and Johnson Gráfico

Noticias Relacionadas

20 ago 2024, 12:16 UTC

Adquisiciones, fusiones, absorciones

Johnson & Johnson to Buy V-Wave for Upfront Payment of $600 Million

20 ago 2024, 11:43 UTC

Principales Noticias

Johnson & Johnson's Rybrevant, Lazcluze Combo Gets FDA Approval for Type of Advanced Lung Cancer

17 jul 2024, 14:14 UTC

Ganancias

Trending: Johnson & Johnson Beats 2Q Sales Guidance

4 sept 2024, 23:20 UTC

Principales Noticias

Johnson & Johnson Wins Over Longtime Holdout for Talc Settlement -- Update

23 ago 2024, 20:54 UTC

Principales Noticias

J&J Takes Aim at Hospital Drug-Discount Program -- Update

23 ago 2024, 18:09 UTC

Principales Noticias

J&J Takes Aim At Hospital Drug-Discount Program -- WSJ

20 ago 2024, 12:41 UTC

Principales Noticias

Adquisiciones, fusiones, absorciones

Johnson & Johnson Gets FDA Approval for Treatment, Makes Acquisition of Up to $1.7 Billion -- Barrons.com

20 ago 2024, 12:01 UTC

Adquisiciones, fusiones, absorciones

Johnson & Johnson to Buy V-Wave for Upfront Payment of $600M

20 ago 2024, 11:55 UTC

Adquisiciones, fusiones, absorciones

J&J To Acquire V-Wave For Up To $1.7 Billion In Play For Heart Failure Device -- MarketWatch

20 ago 2024, 11:31 UTC

Adquisiciones, fusiones, absorciones

Johnson & Johnson Expects the Transaction to Dilute Adjusted EPS by 24c in 2024 and 6c in 2025 >JNJ

20 ago 2024, 11:31 UTC

Adquisiciones, fusiones, absorciones

Johnson & Johnson Transaction Is Expected to Close Before the End of 2024 >JNJ

20 ago 2024, 11:31 UTC

Adquisiciones, fusiones, absorciones

Johnson & Johnson Will Join Johnson & Johnson as Part of Johnson & Johnson MedTech >JNJ

20 ago 2024, 11:31 UTC

Adquisiciones, fusiones, absorciones

Johnson & Johnson Will Acquire V-Wave for an Upfront Payment of $600M With the Potential for Additional Regulatory and Comml Milestone Payments Up to $1.1B >JNJ

20 ago 2024, 11:30 UTC

Adquisiciones, fusiones, absorciones

Johnson & Johnson To Acquire V-Wave >JNJ

20 ago 2024, 11:12 UTC

Principales Noticias

Johnson & Johnson Wins First FDA Approval For Chemotherapy-Free Lung Cancer Treatment -- MarketWatch

12 ago 2024, 14:30 UTC

Adquisiciones, fusiones, absorciones

Correction to Big Drugmakers Are Clinching Smaller Deals Article -- WSJ

12 ago 2024, 09:30 UTC

Principales Noticias

Adquisiciones, fusiones, absorciones

Big Drugmakers Are Clinching Smaller Deals -- WSJ

29 jul 2024, 10:30 UTC

Principales Noticias

Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ

17 jul 2024, 11:24 UTC

Charlas de Mercado

Ganancias

Adquisiciones, fusiones, absorciones

J&J Lifts Sales View But Lowers Earnings Outlook -- Market Talk

17 jul 2024, 10:43 UTC

Ganancias

Johnson & Johnson Earnings Top, But Dow Stock Falls On Lowered Guidance -- IBD

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson: MedTech Operational Sales Growth Expected to Accelerate in 2H >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson Cuts 2024 View To Adj EPS $9.97-Adj EPS $10.07 Vs Prior View $10.57-$10.72 >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson Backs 2024 Adjusted Operational Sales Growth View of 5.5%-6% >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson: 2Q MedTech Worldwide Operational Sales Growth Was Driven Primarily by Electrophysiology Products and Abiomed in Cardiovascular, and Wound Closure Products in General Surgery >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson Backs 2024 Sales $88.0B-$88.4B >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson Cuts 2024 Adjusted Operational EPS View to $10.00-$10.10 Vs Prior View $10.60-$10.75 >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson: 2Q Innovative Medicine Worldwide Operational Sales, Excluding Covid Vaccine, Grew 8.8% >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson Updating 2024 Guidance to Reflect Improved Performance and Impact for Recent Acquisitions of Shockwave Medical, Proteologix and NM26 Bispecific Antibody >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson Raises 2024 Operational Sales View to $89.2B-$89.6B Vs Prior View $88.7B-$89.1B >JNJ

17 jul 2024, 10:20 UTC

Ganancias

Johnson & Johnson 2Q Worldwide MedTech Sales $7.96B >JNJ

Comparación entre iguales

Cambio de precio

Johnson and Johnson Esperado

Precio Objetivo

By TipRanks

4.92% repunte

Estimación a 12 meses

Media 172.46 USD 4.92%

Máximo 215 USD

Mínimo 150 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Johnson and Johnson Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

14 ratings

Comprar

Mantener

Vender

De acuerdo con 14 analistas que ofrecen calificaciones bursátiles a para Johnson and Johnson Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

164.13 / 164.61Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentimiento

By Acuity

293 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Johnson and Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.